175 related articles for article (PubMed ID: 29251255)
1. Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.
Duong-Thi-Ly H; Nguyen-Thi-Thu H; Nguyen-Hoang L; Nguyen-Thi-Bich H; Craig TJ; Duong-Quy S
J Int Med Res; 2017 Dec; 45(6):1818-1830. PubMed ID: 29251255
[TBL] [Abstract][Full Text] [Related]
2.
Voorhies K; Mohammed A; Chinthala L; Kong SW; Lee IH; Kho AT; McGeachie M; Mandl KD; Raby B; Hayes M; Davis RL; Wu AC; Lutz SM
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674355
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
Ye YM; Lee HY; Kim SH; Jee YK; Lee SK; Lee SH; Park HS
J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
[TBL] [Abstract][Full Text] [Related]
4. GLCCI1 and STIP1 variants are associated with asthma susceptibility and inhaled corticosteroid response in a Tunisian population.
Salhi M; Lahmar O; Salah MO; Banić I; Binghao B; Malik W; Hamzaoui K; Turkalj M; Hamzaoui A
J Asthma; 2021 Feb; 58(2):197-206. PubMed ID: 31516081
[No Abstract] [Full Text] [Related]
5. GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.
Izuhara Y; Matsumoto H; Kanemitsu Y; Izuhara K; Tohda Y; Horiguchi T; Kita H; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
Allergy; 2014 May; 69(5):668-73. PubMed ID: 24673601
[TBL] [Abstract][Full Text] [Related]
6. Effects of STIP1 and GLCCI1 polymorphisms on the risk of childhood asthma and inhaled corticosteroid response in Chinese asthmatic children.
Huang J; Hu X; Zheng X; Kuang J; Liu C; Wang X; Tang Y
BMC Pulm Med; 2020 Nov; 20(1):303. PubMed ID: 33208131
[TBL] [Abstract][Full Text] [Related]
7. Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids.
Tsartsali L; Papadopoulos M; Lagona E; Papadimitriou A; Kanaka-Gantenbein C; Louizou E; Kastania A; Priftis KN; Chrousos G
Neuroimmunomodulation; 2012; 19(2):88-95. PubMed ID: 22248724
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
[TBL] [Abstract][Full Text] [Related]
9. Correlations between exhaled nitric oxide, rs28364072 polymorphism of FCER2 gene, asthma control, and inhaled corticosteroid responsiveness in children with asthma.
Duong-Quy S; Le-Thi-Minh H; Nguyen-Thi-Bich H; Pham-Thu H; Thom VT; Pham-Thi-Hong N; Duong-Thi-Ly H; Nguyen-Huy B; Ngo-Minh X; Nguyen-Thi-Dieu T; Craig TJ
J Breath Res; 2020 Nov; 15(1):016012. PubMed ID: 33108776
[TBL] [Abstract][Full Text] [Related]
10. Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.
Jin Y; Hu D; Peterson EL; Eng C; Levin AM; Wells K; Beckman K; Kumar R; Seibold MA; Karungi G; Zoratti A; Gaggin J; Campbell J; Galanter J; Chapela R; Rodríguez-Santana JR; Watson HG; Meade K; Lenoir M; Rodríguez-Cintrón W; Avila PC; Lanfear DE; Burchard EG; Williams LK
J Allergy Clin Immunol; 2010 Sep; 126(3):618-25.e1-2. PubMed ID: 20673984
[TBL] [Abstract][Full Text] [Related]
11. FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children.
Koster ES; Maitland-van der Zee AH; Tavendale R; Mukhopadhyay S; Vijverberg SJ; Raaijmakers JA; Palmer CN
Allergy; 2011 Dec; 66(12):1546-52. PubMed ID: 21958076
[TBL] [Abstract][Full Text] [Related]
12. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma.
Tantisira KG; Silverman ES; Mariani TJ; Xu J; Richter BG; Klanderman BJ; Litonjua AA; Lazarus R; Rosenwasser LJ; Fuhlbrigge AL; Weiss ST
J Allergy Clin Immunol; 2007 Dec; 120(6):1285-91. PubMed ID: 17980418
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation.
Keskin O; Uluca Ü; Birben E; Coşkun Y; Ozkars MY; Keskin M; Kucukosmanoglu E; Kalayci O
Pediatr Allergy Immunol; 2016 Aug; 27(5):507-13. PubMed ID: 27003716
[TBL] [Abstract][Full Text] [Related]
14. ST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults.
Vijverberg SJ; Koster ES; Tavendale R; Leusink M; Koenderman L; Raaijmakers JA; Postma DS; Koppelman GH; Turner SW; Mukhopadhyay S; Tse SM; Tantisira KG; Hawcutt DB; Francis B; Pirmohamed M; Pino-Yanes M; Eng C; Burchard EG; Palmer CN; Maitland-van der Zee AH
Clin Exp Allergy; 2015 Jun; 45(6):1051-9. PubMed ID: 25616159
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review.
Farzan N; Vijverberg SJ; Arets HG; Raaijmakers JA; Maitland-van der Zee AH
Clin Exp Allergy; 2017 Feb; 47(2):271-293. PubMed ID: 27790783
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids.
Vijverberg SJ; Tavendale R; Leusink M; Koenderman L; Raaijmakers JA; Postma DS; Koppelman GH; Turner SW; Mukhopadhyay S; Palmer CN; Maitland-van der Zee AH
Pharmacogenomics; 2014 Apr; 15(6):799-806. PubMed ID: 24897287
[TBL] [Abstract][Full Text] [Related]
17. Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma.
Berce V; Kozmus CE; Potočnik U
Pharmacogenomics J; 2013 Dec; 13(6):523-9. PubMed ID: 22986918
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma.
Edris A; de Roos EW; McGeachie MJ; Verhamme KMC; Brusselle GG; Tantisira KG; Iribarren C; Lu M; Wu AC; Stricker BH; Lahousse L
Clin Exp Allergy; 2022 Jan; 52(1):33-45. PubMed ID: 33428814
[TBL] [Abstract][Full Text] [Related]
19. Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy.
Hodyl NA; Stark MJ; Osei-Kumah A; Bowman M; Gibson P; Clifton VL
Am J Respir Crit Care Med; 2011 Mar; 183(6):716-22. PubMed ID: 20935111
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma.
Tantisira KG; Lazarus R; Litonjua AA; Klanderman B; Weiss ST
Pharmacogenet Genomics; 2008 Aug; 18(8):733-7. PubMed ID: 18622266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
